$332.88
▲ +$1.41
(+0.43%)
Vol 21K
Mkt Cap
$13.0B
P/E
73.4
ROE
13.4%
Margin
12.7%
Beta
0.77
52W
$221–$362
Wall Street Consensus
22 analysts · Apr 20263
Strong Buy
5
Buy
14
Hold
0
Sell
0
Strong Sell
36.4%
Buy Rating
Price Chart
Similar Stocks
RMD
Resmed Inc
P/E 22.0
$32.7B
DXCM
Dexcom Inc
P/E 35.9
$25.9B
ZBH
Zimmer Biomet Holdings, Inc
P/E 26.7
$18.8B
PODD
Insulet Corp
P/E 81.2
$20.0B
GMED
Globus Medical Inc
P/E 23.7
$12.8B
MASI
Masimo Corp
$7.0B
BAX
Baxter International Inc
$9.3B
GKOS
Glaukos Corp
$7.1B
TFX
Teleflex Inc
$5.7B
ABT
Abbott Laboratories
P/E 26.3
$165.2B
Earnings
Beat rate: 100.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $1.12 | $1.18 | +$0.06 |
| Sep 2025 | $0.93 | $0.97 | +$0.04 |
| Jun 2025 | $0.83 | $0.86 | +$0.03 |
| Mar 2025 | $0.67 | $0.83 | +$0.16 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $315.5M | $324.1M | $339.5M | $354.7M | $385.4M |
| Net Income | — | $33.7M | $39.2M | $45.3M | $45.9M | $47.3M |
Fundamentals Trend
| Metric | 2026-04-12 | 2026-04-17 |
|---|---|---|
| ROE (TTM) | 13.4% | 13.4% |
| P/E (TTM) | 72.98 | 73.36 |
| Net Margin | 12.7% | 12.7% |
| Gross Margin | 67.1% | 67.1% |
| D/E Ratio | — | — |
| Current Ratio | 6.64 | 6.64 |
Key Ratios
ROA (TTM)
10.4%
P/S (TTM)
9.29
P/B
8.5
EPS (TTM)
$4.52
CF/Share
$1.73
Rev Growth 3Y
+18.3%
52W High
$362.41
52W Low
$221.26
$221.26
52-Week Range
$362.41
Financial Health
Free Cash Flow
$68.0M
Net Debt
$32.8M
Cash
$186.9M
Total Debt
$219.7M
As of Dec 31, 2025
How does PEN compare to Health Care peers?
Peer group: Peers · Health Care (Peers) · 10 companies
PEN valuation vs Health Care peers
P/E ratio
73.0
▲
178%
above
peers
(26.3)
vs Peers
vs Industry
Overvalued
P/S ratio
9.2
▲
87%
above
peers
(4.9)
vs Peers
vs Industry
Overvalued
P/B ratio
8.5
▲
62%
above
peers
(5.3)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(1.1%)
vs Peers
vs Industry
In line
PEN profitability vs Health Care peers
ROE
13.4%
▼
15%
below
peers
(15.9%)
vs Peers
vs Industry
In line
Net margin
12.7%
▼
8%
below
peers
(13.7%)
vs Peers
vs Industry
In line
Gross margin
67.1%
▲
10%
above
peers
(61.3%)
vs Peers
vs Industry
In line
ROA
10.4%
▲
15%
above
peers
(9.0%)
vs Peers
vs Industry
In line
PEN financial health vs Health Care peers
D/E ratio
—
▼
0%
below
peers
(82.5)
vs Peers
vs Industry
In line
Current ratio
6.6
▲
273%
above
peers
(1.8)
vs Peers
vs Industry
Strong liquidity
Beta
0.8
▼
22%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
PEN fundamentals radar
PEN
Peer median
Industry
PEN profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
PEN vs peers: key metrics
Insider Activity
BearishBuys
10
Sells
2
$865296
GREWAL HARPREET SINGH
Director · Apr 02
sale
100 shs
YUEN MAGGIE S.
Chief Financial Officer · Mar 02
sale
2432 shs
ROBERTS JOHANNA
General Counsel · Feb 17
award
5260 shs
YUEN MAGGIE S.
Chief Financial Officer · Feb 17
award
5260 shs
SHIU LAMBERT
Officer · Feb 17
award
4600 shs
NARAYAN SHRUTHI
President · Feb 17
award
5260 shs
BOSE ARANI
Director · Feb 13
award
589 shs
O'ROURKE BRIDGET A
Director · Feb 13
award
589 shs
LEEDS JANET
Director · Feb 13
award
589 shs
SARNA SURBHI
Director · Feb 13
award
589 shs
Last 90 days
Top Holders
Top 5: 40.38%FMR, LLC
13.08%
$1.7B
Blackrock Inc.
10.55%
$1.4B
Vanguard Group Inc
9.61%
$1.2B
Price (T.Rowe) Associates I…
4.19%
$542.2M
State Street Corporation
2.95%
$381.7M
As of Dec 31, 2025
Latest News
3 Powerhouse Defense Stocks That Can't Be Ignored as Trump Ramps Up …
Nasdaq · Apr 17
Oil prices plunge as Iran says Strait of Hormuz 'open' during ceasefire
BBC Business · Apr 17
Swiss Stocks Rise After Iran Opens Strait Of Hormuz To Commercial Traffic
Nasdaq · Apr 17
The Strait of Hormuz is Now Open! Or Is It? Here's How …
Nasdaq · Apr 17
3 Defense Tech Stocks Central to U.S. Battle Networks as Trump Ramps …
Nasdaq · Apr 17